Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Immunotherapy and Relevant Antibody-Drug Conjugates in Gynecologic Oncology: Recent Advances, Ongoing Challenges, and Future Directions.
Journal: Cancers
Published: May 27, 2026
Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.
Journal: Gynecologic oncology
Published: April 08, 2026
GLP-1 Receptor Agonists Plus Progestins and Endometrial Cancer Risk in Nonmalignant Uterine Diseases.
Journal: JAMA network open
Published: February 10, 2026
Impact of GLP-1 RA plus progestin therapy on fertility-sparing management of endometrial intraepithelial neoplasia and endometrial cancer.
Journal: Gynecologic oncology
Published: January 19, 2026
Association of glutaminase expression with immune-suppressive tumor microenvironment, clinicopathologic features, and clinical outcomes in endometrial cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 16, 2024
Utilization and cost of cell salvage in minimally invasive myomectomy.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: October 06, 2022
ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 10, 2022
Case Report: Tubal Atypical Placental Site Nodule.
Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Published: September 27, 2021
Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma.
Journal: The Journal of pathology
Published: April 17, 2020
Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 11, 2020
Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.
Journal: Cancer research
Published: December 26, 2019
Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
Journal: Gynecologic oncology
Published: November 09, 2019
Last Updated: 11/08/2026